Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CSTL	CASTLE BIOSCIENCES INC	$587.55M	-1.20%	-1.00%	-0.35%	-0.60%	0.14	9.37	81.90%	-1.50%	-0.47%
ETNB	89BIO INC	$1.44B	-81.40%	-70.20%	-58.76%	-105.30%	0.13	18.03	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$1.44B	-40.60%	-34.50%	-28.55%	-34.30%	0.14	27.68	N/A	N/A	N/A
MGX	METAGENOMI INC	$54.58M	-32.10%	-22.80%	-32.32%	-27.50%	0.40	5.85	100.00%	-172.20%	-184.18%
OSUR	ORASURE TECHNOLOGIES INC	$225.15M	-7.70%	-6.80%	-7.08%	-21.60%	0.16	12.34	41.80%	-19.80%	-18.93%
VRDN	VIRIDIAN THERAPEUTICS INC	$1.17B	-49.10%	-44.70%	-48.67%	-56.50%	0.09	19.49	100.00%	-102,092.40%	-101,084.11%
NTLA	INTELLIA THERAPEUTICS INC	$990.26M	-58.70%	-46.30%	-60.20%	-51.60%	0.26	4.90	100.00%	-1,154.10%	-1,154.10%
APLS	APELLIS PHARMACEUTICALS INC	$2.19B	-100.10%	-25.60%	-28.28%	-22.80%	3.92	4.08	83.00%	-28.80%	-22.93%
ARDX	ARDELYX INC	$882.85M	-34.40%	-13.80%	-11.34%	-9.50%	1.82	4.12	84.60%	-14.90%	-10.48%
CING	CINGULATE INC	$17.20M	-229.80%	-142.30%	-238.91%	-626.10%	1.10	1.87	N/A	N/A	N/A
VYGR	VOYAGER THERAPEUTICS INC	$163.80M	-27.40%	-21.10%	-26.84%	-28.50%	0.30	6.10	100.00%	-140.00%	-138.89%
MIRA	MIRA PHARMACEUTICALS INC	$21.06M	-341.10%	-272.90%	-620.78%	1,867.30%	0.08	12.86	N/A	N/A	N/A
ANNX	ANNEXON INC	$264.41M	-54.50%	-46.60%	-62.11%	-62.80%	0.24	7.99	N/A	N/A	N/A
ANVS	ANNOVIS BIO INC	$39.95M	-300.60%	-193.50%	-119.92%	2,241.60%	0.11	10.68	N/A	N/A	N/A
NKTX	NKARTA INC	$117.79M	-26.60%	-21.60%	-24.62%	-21.80%	0.24	14.48	N/A	N/A	N/A
ALMS	ALUMIS INC	$164.30M	-406.30%	-107.30%	-170.95%	-245.10%	0.55	3.73	100.00%	-1,974.50%	-1,974.51%
VSTM	VERASTEM INC	$228.04M	N/A	-128.00%	-150.99%	-447.30%	-5.06	3.50	100.00%	-1,488.80%	-1,450.68%
SLXN	SILEXION THERAPEUTICS CORP	$6.95M	N/A	-319.50%	-207.97%	-362.70%	2.21	3.22	N/A	N/A	N/A
ONCY	ONCOLYTICS BIOTECH INC	$64.90M	-316.30%	-131.00%	-225.15%	8,462.00%	2.03	3.21	N/A	N/A	N/A
IOVA	IOVANCE BIOTHERAPEUTICS INC	$564.35M	-49.70%	-39.20%	-44.86%	-85.40%	0.26	4.18	21.70%	-176.50%	-178.03%
OTLK	OUTLOOK THERAPEUTICS INC	$53.71M	-35.30%	75.40%	-367.87%	414.00%	-1.59	0.72	N/A	N/A	N/A
ZYXI	ZYNEX INC	$77.11M	-23.70%	-6.20%	-8.51%	-6.70%	4.09	3.46	77.70%	-4.30%	-4.42%
ARTV	ARTIVA BIOTHERAPEUTICS INC	$35.81M	-78.50%	-40.80%	-40.05%	-49.60%	0.13	13.93	N/A	N/A	N/A
TNYA	TENAYA THERAPEUTICS INC	$99.23M	-92.20%	-74.50%	-81.48%	-96.90%	0.21	6.68	N/A	N/A	N/A
TYRA	TYRA BIOSCIENCES INC	$483.92M	-27.50%	-26.10%	-29.29%	-36.60%	0.06	22.78	N/A	N/A	N/A
TELO	TELOMIR PHARMACEUTICALS INC	$45.54M	-2,009.60%	-1,009.70%	7,774.94%	2,642.40%	-4.05	0.75	N/A	N/A	N/A
IMVT	IMMUNOVANT INC	$2.75B	-80.60%	-71.90%	-58.37%	2,444.00%	0.10	11.16	N/A	N/A	N/A
BFRG	BULLFROG AI HOLDINGS INC	$14.22M	-163.90%	-140.50%	-218.44%	2,849.60%	0.26	4.86	N/A	N/A	N/A
PHAT	PHATHOM PHARMACEUTICALS INC	$679.99M	N/A	-100.30%	-123.94%	-53.20%	-1.87	3.58	86.20%	-422.40%	-333.35%
CGEM	CULLINAN THERAPEUTICS INC	$457.95M	-29.70%	-28.40%	-32.34%	-34.60%	0.05	11.62	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$202.66M	-22.90%	-22.00%	-24.52%	-25.40%	0.04	28.37	N/A	N/A	N/A
BCAX	BICARA THERAPEUTICS INC	$475.01M	N/A	N/A	N/A	N/A	0.04	24.62	N/A	N/A	N/A
CTNM	CONTINEUM THERAPEUTICS INC	$106.33M	-24.60%	-23.50%	-26.32%	-29.70%	0.07	21.47	N/A	N/A	N/A
SANA	SANA BIOTECHNOLOGY INC	$633.81M	-76.50%	-39.30%	-50.61%	-81.20%	1.13	3.40	N/A	N/A	N/A
CYBN	CYBIN INC	$163.01M	-39.00%	-37.70%	-43.25%	-841.30%	0.06	12.60	N/A	N/A	N/A
KAPA	KAIROS PHARMA LTD	$11.27M	-112.60%	-71.80%	-49.33%	-290.40%	0.11	7.52	N/A	N/A	N/A
BCTX	BRIACELL THERAPEUTICS CORP	$20.06M	-475.70%	-184.00%	33.59%	-399.30%	0.42	3.41	N/A	N/A	N/A
LGVN	LONGEVERON INC	$19.81M	-128.50%	-106.90%	-93.38%	-560.50%	0.22	5.61	82.30%	-1,149.40%	-760.63%
LFWD	LIFEWARD LTD	$7.38M	-102.00%	-70.50%	-139.08%	-351.80%	0.56	2.19	35.20%	-108.20%	-108.02%
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$1.51M	-1,202.90%	-370.40%	-276.22%	-2,354.50%	0.62	2.78	N/A	N/A	N/A
CYTK	CYTOKINETICS INC	$3.96B	N/A	-43.70%	-52.14%	-29.40%	-5.75	5.99	100.00%	-3,201.50%	-2,996.11%
REPL	REPLIMUNE GROUP INC	$719.22M	-58.00%	-45.20%	-48.87%	-54.70%	0.33	7.95	N/A	N/A	N/A
LUCD	LUCID DIAGNOSTICS INC	$106.42M	-1,270.60%	-236.00%	1,637.57%	-1,049.00%	-7.10	0.75	-67.60%	-1,699.90%	-1,481.00%
OCS	OCULIS HOLDING AG	$1.08B	-92.70%	-69.90%	-62.07%	-169.90%	0.26	4.79	100.00%	-13,737.90%	-13,649.68%
SINT	SINTX TECHNOLOGIES INC	$8.08M	-203.70%	-104.80%	-134.12%	-142.80%	0.88	3.45	25.50%	-483.80%	-482.29%
PHVS	PHARVARIS NV	$926.38M	-54.40%	-50.70%	N/A	-1,673.40%	0.10	N/A	N/A	N/A	N/A
VOR	VOR BIOPHARMA INC	$132.46M	-142.10%	-93.10%	-128.09%	-155.50%	0.66	3.88	N/A	N/A	N/A
ANRO	ALTO NEUROSCIENCE INC	$62.54M	-39.80%	-34.20%	-37.38%	-415.50%	0.24	22.53	N/A	N/A	N/A
GRI	GRI BIO INC	$2.72M	-331.30%	-202.60%	-743.15%	753.30%	2.35	1.41	N/A	N/A	N/A
PLRZ	POLYRIZON LTD	$12.40k	-60.60%	-50.60%	-24.63%	-2,578.20%	0.05	10.17	N/A	N/A	N/A
ABOS	ACUMEN PHARMACEUTICALS INC	$67.84M	-58.20%	-46.50%	-60.57%	-51.70%	0.32	8.02	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$1.47B	-58.80%	-41.20%	-48.97%	-183.60%	0.53	10.22	90.70%	-323.10%	-302.12%
HOWL	WEREWOLF THERAPEUTICS INC	$45.77M	-89.40%	-54.90%	-70.63%	-165.10%	0.87	8.10	100.00%	-6,335.20%	-5,905.07%
IMRX	IMMUNEERING CORP	$127.03M	-119.20%	-99.20%	-135.55%	-718.20%	0.21	7.48	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$79.74M	-43.90%	-42.90%	-48.00%	-102.60%	0.04	14.25	N/A	N/A	N/A
NGNE	NEUROGENE INC	$230.47M	-36.20%	-32.50%	-26.84%	-53.80%	0.08	21.03	N/A	N/A	N/A
COGT	COGENT BIOSCIENCES INC	$808.38M	-92.70%	-75.60%	-114.93%	-121.30%	0.30	5.13	N/A	N/A	N/A
TPST	TEMPEST THERAPEUTICS INC	$25.41M	-305.50%	-119.70%	-230.10%	-316.80%	1.89	1.70	N/A	N/A	N/A
HYPR	HYPERFINE INC	$57.76M	-74.20%	-62.40%	-88.75%	-311.00%	0.24	6.07	46.20%	-343.40%	-343.42%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$84.90M	-65.50%	-51.00%	-66.99%	-59.00%	0.30	6.94	100.00%	552.70%	552.64%
CBUS	CIBUS INC	$48.48M	-203.20%	-68.40%	-76.61%	-92.90%	3.72	1.23	100.00%	-5,784.90%	-5,063.86%
KALV	KALVISTA PHARMACEUTICALS INC	$567.26M	-106.80%	-80.60%	-67.41%	-128.10%	0.90	10.44	N/A	N/A	N/A
GUTS	FRACTYL HEALTH INC	$80.32M	-228.70%	-76.70%	-138.71%	-102.70%	12.03	2.50	48.30%	-148,511.70%	-148,511.67%
MIST	MILESTONE PHARMACEUTICALS INC	$99.44M	-329.60%	-67.10%	-98.69%	-48.30%	-11.11	4.67	N/A	N/A	N/A
GPCR	STRUCTURE THERAPEUTICS INC	$1.21B	-16.30%	-15.70%	-17.22%	-21.40%	0.05	23.29	N/A	N/A	N/A
AVBP	ARRIVENT BIOPHARMA INC	$783.81M	-49.30%	-46.70%	-62.93%	-154.70%	0.06	14.34	N/A	N/A	N/A
BMEA	BIOMEA FUSION INC	$68.01M	-197.70%	-134.80%	-365.02%	-1,898.50%	0.92	2.26	N/A	N/A	N/A
CLDX	CELLDEX THERAPEUTICS INC	$1.35B	-23.50%	-22.40%	-25.28%	-25.10%	0.05	21.67	100.00%	-2,366.10%	-2,366.07%
CELC	CELCUITY INC	$474.84M	-96.20%	-49.40%	-62.15%	-37.50%	1.52	6.61	N/A	N/A	N/A
CDXS	CODEXIS INC	$198.00M	-118.50%	-53.40%	-58.90%	-47.00%	1.60	3.72	71.60%	-149.50%	-127.68%
KPTI	KARYOPHARM THERAPEUTICS INC	$37.93M	N/A	-36.00%	-53.47%	-8.80%	-1.62	1.33	96.20%	-44.00%	-14.05%
NYXH	NYXOAH SA	$279.58M	-64.70%	-47.60%	-50.97%	-84.20%	0.46	3.59	65.50%	-1,597.50%	-1,342.26%
TERN	TERNS PHARMACEUTICALS INC	$334.50M	-28.80%	-27.50%	-27.45%	-59.60%	0.04	30.89	N/A	N/A	N/A
SLDB	SOLID BIOSCIENCES INC	$365.87M	-70.50%	-57.30%	-44.22%	-106.10%	0.17	10.89	N/A	N/A	N/A
ATNM	ACTINIUM PHARMACEUTICALS INC	$44.30M	-129.60%	-57.30%	-73.96%	1,572.10%	1.67	9.35	N/A	N/A	N/A
PRME	PRIME MEDICINE INC	$317.73M	-125.10%	-66.30%	-68.79%	-97.60%	2.07	4.78	100.00%	-5,252.50%	-5,255.98%
CMPS	COMPASS PATHWAYS PLC	$259.17M	-71.60%	-52.10%	-45.50%	-246.50%	0.63	10.18	N/A	N/A	N/A
ABCL	ABCELLERA BIOLOGICS INC	$1.08B	-15.70%	-12.20%	-16.60%	-19.30%	0.31	10.15	100.00%	-726.20%	-911.24%
SKYE	SKYE BIOSCIENCE INC	$127.35M	-47.30%	-42.60%	-54.36%	-1,549.40%	0.09	11.85	N/A	N/A	N/A
ADVM	ADVERUM BIOTECHNOLOGIES INC	$48.47M	-149.70%	-76.00%	-136.07%	-91.80%	4.21	3.57	100.00%	-15,315.90%	-15,315.90%
EVH	EVOLENT HEALTH INC	$1.31B	-13.90%	-5.50%	-4.61%	-13.10%	1.63	0.99	15.20%	-5.90%	-3.68%
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$90.55M	-36.90%	-32.90%	-38.39%	-39.80%	0.10	11.82	N/A	N/A	N/A
DNTH	DIANTHUS THERAPEUTICS INC	$566.98M	-29.30%	-27.90%	-30.38%	-40.00%	0.06	15.99	100.00%	-1,544.00%	-1,544.02%
PRAX	PRAXIS PRECISION MEDICINES INC	$875.87M	-50.40%	-46.70%	-48.40%	-85.00%	0.09	8.44	100.00%	-2,617.10%	-2,617.11%
ACHV	ACHIEVE LIFE SCIENCES INC	$77.35M	-176.10%	-103.30%	-220.53%	-133.50%	1.66	3.51	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$2.05B	-35.90%	-32.40%	-38.48%	-36.00%	0.13	9.56	N/A	N/A	N/A
INBX	INHIBRX BIOSCIENCES INC	$208.89M	1,101.20%	762.10%	869.86%	10,965.20%	1.57	5.12	100.00%	861,485.50%	865,511.50%
CTXR	CITIUS PHARMACEUTICALS INC	$15.74M	-61.20%	-37.80%	-57.58%	-62.70%	0.96	0.37	N/A	N/A	N/A
SAVA	CASSAVA SCIENCES INC	$84.54M	-46.30%	-38.00%	-57.00%	2,207.70%	0.10	9.08	N/A	N/A	N/A
NKTR	NEKTAR THERAPEUTICS	$319.60M	-262.10%	-43.90%	-57.01%	-34.20%	17.65	3.24	74.60%	-152.50%	-121.08%
NMRA	NEUMORA THERAPEUTICS INC	$122.44M	-84.80%	-77.60%	-112.88%	-195.80%	0.12	8.98	N/A	N/A	N/A
BHVN	BIOHAVEN LTD	$1.44B	-257.10%	-164.00%	-301.05%	-336.50%	0.77	2.33	N/A	N/A	N/A
KOD	KODIAK SCIENCES INC	$195.23M	-115.70%	-54.20%	-71.39%	-61.30%	1.74	4.62	N/A	N/A	N/A
PLRX	PLIANT THERAPEUTICS INC	$76.73M	-67.60%	-52.50%	-68.28%	-59.60%	0.34	11.03	N/A	N/A	N/A
IMUX	IMMUNIC INC	$67.07M	-326.90%	-181.30%	1,898.68%	558.80%	-4.88	0.74	N/A	N/A	N/A
RCUS	ARCUS BIOSCIENCES INC	$841.79M	-70.60%	-33.00%	-40.04%	-46.00%	1.18	5.37	100.00%	-277.30%	-273.76%
FBLG	FIBROBIOLOGICS INC	$23.65M	-564.30%	-64.90%	-237.98%	520.60%	3.86	1.14	N/A	N/A	N/A
CDT	CONDUIT PHARMACEUTICALS INC	$2.30M	N/A	-435.60%	-643.09%	6,952.40%	1.73	1.31	N/A	N/A	N/A
RXRX	RECURSION PHARMACEUTICALS INC	$2.04B	-74.70%	-54.00%	-49.45%	-241.60%	0.40	4.11	6.50%	-961.30%	-962.17%
PEPG	PEPGEN INC	$37.63M	-81.30%	-63.70%	-96.09%	-94.40%	0.39	4.95	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	651	-0.86%	+1.66%	+3.82%	-71.04%	-123.86x	4.44x	-78.67%	-3.10%	+5.17%	+105.31%	Strong Buy
Diagnostics & Research	57	-0.20%	+1.70%	+3.90%	-18.06%	19.52x	3.55x	-11.03%	+5.90%	+10.56%	+15.00%	Buy
Drug Manufacturers - General	18	-1.14%	+0.49%	+2.53%	-13.20%	37.73x	5.91x	+50.79%	+9.87%	+16.81%	+56.00%	Buy
Drug Manufacturers - Specialty & Generic	77	-0.54%	-3.06%	+0.75%	-60.50%	-31.27x	2.23x	+9.58%	+4.64%	+10.61%	+39.90%	Buy
Healthcare Plans	11	+1.17%	+1.88%	+2.55%	-20.99%	14.43x	2.06x	+16.73%	+5.27%	+12.28%	+23.54%	Buy
Health Information Services	56	+1.14%	+5.74%	+4.64%	-63.83%	46.11x	4.04x	+8.05%	+4.31%	+9.42%	+18.70%	Buy
Medical Care Facilities	48	+0.38%	+2.07%	-0.55%	-8.57%	16.78x	4.66x	-73.33%	+6.80%	+14.32%	+19.11%	Buy
Medical Devices	139	+0.34%	+2.78%	+0.80%	-9.33%	37.15x	4.13x	+8.21%	+8.33%	+8.98%	+29.58%	Strong Buy
Medical Distribution	10	+0.68%	+1.34%	+2.04%	+26.23%	29.20x	1,406.44x	-0.53%	+3.60%	+22.82%	+4.00%	Buy
Medical Instruments & Supplies	56	+0.23%	+2.85%	-0.48%	-61.26%	41.77x	3.70x	+10.31%	+8.51%	+10.99%	+25.85%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jul 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 19 points higher than the healthcare sector average of 26. It passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 49.88% over the past year, overperforming other healthcare stocks by 101 percentage points.

Phibro Animal Health has an average 1 year price target of $24.00, a downside of -6.47% from Phibro Animal Health's current stock price of $25.66.

Phibro Animal Health stock has a consensus Sell recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 0% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 50% have issued a Strong Sell.

2. Healthcare Services Group (NASDAQ:HCSG)

Healthcare Services Group (NASDAQ:HCSG) is the #2 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Healthcare Services Group (NASDAQ:HCSG) is: Value: C, Growth: B, Momentum: B, Sentiment: B, Safety: A, Financials: C, and AI: B.

Healthcare Services Group (NASDAQ:HCSG) has a Due Diligence Score of 41, which is 15 points higher than the healthcare sector average of 26. It passed 16 out of 38 due diligence checks and has strong fundamentals. Healthcare Services Group has seen its stock return 38.02% over the past year, overperforming other healthcare stocks by 89 percentage points.

Healthcare Services Group has an average 1 year price target of $14.00, a downside of -6.23% from Healthcare Services Group's current stock price of $14.93.

Healthcare Services Group stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Healthcare Services Group, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) is the #3 top healthcare stock out of 1123 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Cumberland Pharmaceuticals (NASDAQ:CPIX) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: C.

Cumberland Pharmaceuticals (NASDAQ:CPIX) has a Due Diligence Score of 30, which is 4 points higher than the healthcare sector average of 26. It passed 9 out of 33 due diligence checks and has average fundamentals. Cumberland Pharmaceuticals has seen its stock return 126.35% over the past year, overperforming other healthcare stocks by 177 percentage points.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Fresenius Medical Care Ag (NYSE:FMS)

Fresenius Medical Care Ag (NYSE:FMS) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 1.97%. Fresenius Medical Care Ag's dividend payout is not stable, having dropped more than 10% three times in the last 10 years. Fresenius Medical Care Ag's dividend has shown consistent growth over the last 10 years.

Fresenius Medical Care Ag's dividend payout ratio of 52.9% indicates that its dividend yield is sustainable for the long-term.

2. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 12.45%, which is 10 percentage points higher than the healthcare sector average of 1.97%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 32.4% indicates that its high dividend yield is sustainable for the long-term.

3. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 7.71%, which is 6 percentage points higher than the healthcare sector average of 1.97%.

Cryo Cell International's dividend payout ratio of 5,000% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.14% in the last day, and up 1.88% over the last week. Inmune Bio was the among the top losers in the healthcare sector, dropping -56.66% yesterday.

INmune Bio shares are trading lower after Scotiabank downgraded the stock from Sector Outperform to Sector Underperform and lowered its price target from $23 to $0.6. BTIG downgraded the stock from Buy to Neutral.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 3.88% in the past year. It has overperformed other stocks in the healthcare sector by 55 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 26 points higher than the healthcare sector average of 17. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 4.57% in the past year. It has overperformed other stocks in the healthcare sector by 56 percentage points.

3. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Inmode's stock has dropped -19.19% in the past year. It has overperformed other stocks in the healthcare sector by 32 percentage points.

Are healthcare stocks a good buy now?

50.96% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 48.04% over the next year.

4.71% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.11% of healthcare stocks are rated B (Buy), 45.05% are rated C (Hold), 25.97% are rated D (Sell), and 13.16% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 6.71x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Healthcare Services Group (NASDAQ:HCSG)

3. Cumberland Pharmaceuticals (NASDAQ:CPIX)

1. Fresenius Medical Care Ag (NYSE:FMS)

2. Select Medical Holdings (NYSE:SEM)

3. Cryo Cell International (NYSEMKT:CCEL)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Healthcare Services Group (NASDAQ:HCSG)

3. Cumberland Pharmaceuticals (NASDAQ:CPIX)

1. Fresenius Medical Care Ag (NYSE:FMS)

2. Select Medical Holdings (NYSE:SEM)

3. Cryo Cell International (NYSEMKT:CCEL)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.